Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359292 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359134 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL16253 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL15435964 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL337163 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL39624 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL313538 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL128339 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359493 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL271582 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4308066-B1 | RESHAPING COMPOSITION FOR KERATIN FIBERS | KAO GERMANY GMBH (DE) | 2024-05-15 | — | — | EP | claimed |
| CN-114983964-B | Cefdinir granule and preparation method thereof | 广东恒健制药有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117045612-B | Ezetimibe tablet and preparation method thereof | 北京福元医药股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| EP-4308066-A1 | RESHAPING COMPOSITION FOR KERATIN FIBERS | Kao Germany GmbH (DE) | 2024-01-24 | — | — | EP | claimed |
| CN-117045612-A | Ezetimibe tablet and preparation method thereof | 北京福元医药股份有限公司 | 2023-11-14 | — | — | CN | claimed |
| EP-4262684-A1 | INVERSE EMULSION COMPRISING AT LEAST ONE FATTY ALCOHOL, A NON-IONIC SUGAR ESTER, ETHYLCELLULOSE AND METHOD EMPLOYING IT | L'OREAL (FR) | 2023-10-25 | — | — | EP | claimed |
| EP-4262732-A1 | INVERSE EMULSION COMPRISING ETHYL CELLULOSE, AN ETHER OR CARBONATE HYDROCARBON-BASED OIL AND METHOD EMPLOYING SAME | L'OREAL (FR) | 2023-10-25 | — | — | EP | claimed |
| CN-116725924-A | Light-streak repairing lip cream and preparation method thereof | 上海科黛生物科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116583258-A | Inverse emulsion comprising an ethylcellulose, an ether-type or a carbonate-type hydrocarbon-based oil and a method employing the inverse emulsion | 莱雅公司 | 2023-08-11 | — | — | CN | claimed |
| CN-114983964-A | Cefdinir granules and preparation method thereof | 广东恒健制药有限公司 | 2022-09-02 | — | — | CN | claimed |
| US-20060088592-A1 | Oral formulation for delivery of poorly absorbed drugs | BLUTH, STEVEN W. | 2006-04-27 | — | — | US | claimed |
| EP-1601718-A1 | EXTRUDABLE PVC COMPOSITIONS | Honeywell International Inc. (US) | 2005-12-07 | — | — | EP | claimed |
| WO-2005105050-A1 | ORAL FORMULATION FOR DELIVERY OF POORLY ABSORBED DRUGS | PROCARRIER, INC. (US) | 2005-11-10 | — | — | WO | claimed |
| US-20050209375-A1 | Shapeable resin compositions | HONEYWELL INTERNATIONAL INC. (US) | 2005-09-22 | — | — | US | claimed |
| WO-2005015201-A1 | USE OF NON-ABSORBABLE FAT IN DETERMINING DIETARY FAT ABSORPTION | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2005-02-17 | — | — | WO | claimed |
| US-20040259984-A1 | Extrudable PVC compositions | HONEYWELL INTERNATIONAL, INC. | 2004-12-23 | — | — | US | claimed |
| EP-0517211-B1 | Physiologically active polypeptide containing pharmaceutical composition | TEIKOKU SEIYAKU KK (JP) | 2004-09-22 | — | — | EP | claimed |
| WO-2004072167-A1 | EXTRUDABLE PVC COMPOSITIONS | HONEYWELL INTERNATIONAL INC. (US) | 2004-08-26 | — | — | WO | claimed |
| CN-1514725-A | Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester | - | 2004-07-21 | — | — | CN | claimed |
| EP-0517211-A1 | Physiologically active polypeptide containing pharmaceutical composition | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1992-12-09 | — | — | EP | claimed |